81317

Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) full sequence analysis

Medicare pricing data for 87 providers across 10 states

🤖AI Overview

Note: These costs reflect the Medicare physician/supplier component. Hospital facility fees are billed separately and can be 2-5x the physician fee.

💡 What You Should Know

Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) full sequence analysis (HCPCS code 81317) is a medical procedure billed to Medicare. The average Medicare-allowed cost is $662.78, but hospitals typically charge $784.93 — a 1.2x markup. Prices vary significantly by state and provider.

🏷️ Typical Out-of-Pocket Cost

$132.56

Medicare patients typically pay about 20% of the allowed amount as coinsurance. Based on the average allowed cost of $662.78, your out-of-pocket cost would be approximately $132.56. Actual costs depend on your specific plan, deductible, and whether you've met your annual out-of-pocket maximum.

Average Allowed Cost
$662.78
Average Hospital Charge
$784.93
Markup Ratio
1.2x

What Hospitals Charge vs. What Medicare Pays

Hospital Charge$784.93
Medicare Allowed$662.78
Medicare Payment$662.78

Hospitals charge 1.2x more than what Medicare allows for this procedure. Medicare actually pays $662.78 on average.

Cost by State

Medicare-allowed amounts vary significantly by state

StateAllowed CostHospital ChargeProvidersServicesvs. National
Louisiana$663$7313158+0.0%
Mississippi$663$2,030129+0.0%
New York$663$1,919212+0.0%
Oklahoma$663$7842100+0.0%
Pennsylvania$663$67823,181+0.0%
Texas$663$747299,290+0.0%
Florida$663$884242,713-0.0%
New Jersey$663$805166,975-0.0%
Colorado$662$2,8053101-0.1%
Maryland$662$1,0783132-0.1%

⚠️ Important: These costs reflect the Medicare physician/supplier component. Hospital facility fees may be billed separately. Total out-of-pocket costs may be higher.

Related from TheDataProject.ai

💊 Need post-procedure medications? Check costs on OpenPrescriber